Today: 14 July 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio shares were active before the Nasdaq bell on Monday after the company said five U.S. patents will protect its Anktiva-plus-BCG bladder cancer treatment into at least 2035. This statement followed Friday’s announcement of an exclusive U.S. supply deal with Japan BCG Laboratory. The stock last traded at $7.97, unchanged from Friday’s close, when it slipped 2.2% on volume of 11.3 million shares.
18 May 2026
··
1 … 57 58 59 60 61 … 881

Stock Market Today

  • CRDO Jumps on AI Hopes, but Valuation Worries Surface
    July 13, 2026, 10:39 PM EDT. Credo Technology Group Holding (CRDO) is in focus after some analysts flagged its push into AI connectivity solutions for semiconductors. Shares are up 48.5% over the past 90 days and up 140% in one year. The stock dropped about 10% recently. PortfolioPulse sees CRDO as 82.2% overvalued with a fair value at $130, compared to a recent close around $237. The valuation is pricing in fast sales growth and steep earnings multiples. Main risks are softer AI infrastructure spending and possible delays on product launches. For investors, it's a trade between chasing momentum or being wary of rising valuation as the market shifts.
Go toTop